Not Medicare Enrolled

Dr. Alejandro Diaz, M.D.

Pediatric Endocrinology · Miami, FL
Consulting-driven
3100 SW 62ND AVE, Miami, FL 33155
3056628368
In practice since 2006 (19 years)
NPI: 1821185869 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Diaz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Diaz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Diaz

Dr. Alejandro Diaz is a pediatric endocrinology in Miami, FL, with 19 years in practice.

Between the years covered by Open Payments, Dr. Diaz received a total of $26,048 from 47 pharmaceutical and/or device companies across 408 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric endocrinology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Diaz is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $26,048 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$26,048
Total received (2018-2024)
Avg $3,721/year across 7 years
Top 11% in FL for pediatric endocrinology
47
Companies
408
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16,162 (62.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,813 (37.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$74 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$12,202
2023
$1,825
2022
$2,117
2021
$908
2020
$536
2019
$7,172
2018
$1,290

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$10,123
Novo Nordisk Inc
$6,827
Insulet Corporation
$1,368
Alexion Pharmaceuticals, Inc.
$763
SANOFI-AVENTIS U.S. LLC
$640
Tandem Diabetes Care, Inc.
$619
Ascendis Pharma, Inc.
$388
Xeris Pharmaceuticals, Inc.
$378
Dexcom, Inc.
$376
Lilly USA, LLC
$360
Abbott Laboratories
$323
Ascendis Pharma Inc
$302
Eton Pharmaceuticals, Inc.
$256
Ultragenyx Pharmaceutical Inc.
$234
Becton, Dickinson and Company
$204
Ipsen Biopharmaceuticals, Inc
$204
Neurocrine Biosciences, Inc.
$202
Rhythm Pharmaceuticals, Inc.
$199
BETA BIONICS, INC.
$195
Amneal Pharmaceuticals LLC
$184
BioMarin Pharmaceutical Inc.
$176
AbbVie, Inc.
$155
ABBVIE INC.
$149
MannKind Corporation
$142
LifeScan, Inc.
$139
PFIZER INC.
$113
LIFESCAN, INC.
$95
AbbVie Inc.
$91
Endo Pharmaceuticals Inc.
$88
Zealand Pharma US, Inc.
$73
TOLMAR Pharmaceuticals, Inc.
$68
Kyowa Kirin, Inc.
$64
Amphastar Pharmaceuticals, Inc.
$63
IBSA Pharma Inc.
$61
Aegerion Pharmaceuticals, Inc.
$58
Gemini Laboratories, LLC
$54
Embecta Corp.
$42
Ferring Pharmaceuticals Inc.
$40
Amryt Pharma Holdings Ltd
$39
ARBOR PHARMACEUTICALS, INC.
$38
Medtronic, Inc.
$33
DERMIRA, INC.
$25
Companion Medical, Inc.
$21
Endo USA, Inc.
$20
Azurity Pharmaceuticals, Inc.
$19
Arbor Pharmaceuticals, Inc.
$18
Mannkind Corporation
$17
Top 3 companies account for 70.3% of total payments
Associated products mentioned in payments ›
AFREZZA · ALKINDI · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · Creon · Crysvita · DEXCOM G6 CGM SYSTEM · Dexcom CGM · Dexcom G6 Transmitter · FENSOLVI · FIASP · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GENOTROPIN · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMATROPE · IMCIVREE · INCRELEX · Imcivree · InPen · Increlex · Kanuma · LICART · LUPRON DEPOT · Levemir · Lupron Depot · MYALEPT · MYCARELINK · Macrilen · Norditropin · ONETOUCH VERIO REFLECT · OT Verio Flex Starter Kit · Omnipod · OneTouch · OneTouch Verio Reflect · QBREXZA · SKYTROFA · STRENSIQ · SUPPRELIN · SUPPRELIN LA · Skytrofa · Sogroya · Somatuline Depot · Strensiq · Synthroid · TOUJEO · TRIPTODUR · TZIELD · Tirosint · Tresiba · Triptodur · UNITHROID · VOXZOGO · Victoza · Wegovy · ZEGALOGUE · ZOMACTON · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (62%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for a pediatric endocrinology in Miami?
Compare pediatric endocrinologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse pediatric endocrinologys nearby

Geographic Context

Pediatric Endocrinologys within 10 mi
28
Per 100K population
1.0
County median income
$68,694
Nearest hospital
KERALTY HOSPITAL
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Diaz is a pediatric endocrinology, and high industry engagement (consulting-driven, top 11%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Diaz receive payments from pharmaceutical companies?
Yes. Dr. Diaz received a total of $26,048 from 47 companies across 408 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Diaz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatric Endocrinologys in Miami
Browse pediatric endocrinologys in Miami ranked by procedure volume and transparency data.
Highest volume
Top Pediatric Endocrinologys in FL
Pediatric Endocrinologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatric Endocrinologys in FL
Which FL pediatric endocrinologys receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Insulet Corporation Payments to Doctors
See all physicians who received payments from Insulet Corporation.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →